Predictors for vancomycin resistant transforming from colonization to infection: a case control study.

Antimicrob Resist Infect Control

1Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan 100.

Published: July 2020

Background: Little is known about risk factors for subsequent infections among vancomycin resistant (VREfm) colonizers, especially characterized by concordant pulsotypes (CP) of paired colonization and infection-related isolates.

Methods: This case-control study was conducted at a teaching hospital between 2011 and 2014. Targeted patients received active surveillance culture for VREfm by anal swabs at admission. Cases were those who developed VREfm infection within 180 days after colonization of VREfm. Controls were those colonized with VREfm without subsequent VREfm infection. CP were defined by similarities ≥86.7% using pulsed-field gel electrophoresis between paired colonization and infection-related isolates.

Results: Ninety-seven cases and 194 controls were enrolled. By conditional multivariable logistic regression analysis, the risk factors for subsequent infection among VREfm colonizers were intensive care unit (ICU) admission (adjusted odds ratio [aOR], 9.32; 95% CI, 3.61-24.02), receipt of central venous catheters (CVC) (aOR, 3.38; 95% CI, 1.30-8.82), and utilization of third- and fourth-generation cephalosporins (aOR, 4.06; 95% CI, 1.79-9.20, and aOR, 5.32; 95% CI, 1.85- 10.29, respectively) (all  ≤ 0.01). Fifty-six (57.7%) of case patients belonged to the CP group, which were associated with ICU admission (aOR, 3.74; 95% CI, 1.38-10.13), and infection developing within 30 days after colonization (aOR, 3.34; 95% CI, 1.25-8.91).

Conclusions: Among VREfm colonizers, being admitted to ICU and receiving CVC or broad spectrum cephalosporins, were the risk factors for subsequent infections. These findings highlight the importance of conducting more strict infection control measures on specific groups of VREfm colonizers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889723PMC
http://dx.doi.org/10.1186/s13756-019-0647-7DOI Listing

Publication Analysis

Top Keywords

vrefm colonizers
16
risk factors
12
factors subsequent
12
vrefm
9
vancomycin resistant
8
subsequent infections
8
paired colonization
8
colonization infection-related
8
vrefm infection
8
icu admission
8

Similar Publications

Article Synopsis
  • This study investigates vancomycin-resistant Enterococcus faecium (VREfm) in Tunisia, focusing on its molecular characteristics and the genetic factors behind its resistance.
  • The research analyzed 80 VREfm isolates from hospitalized patients over six years, showing a significant increase in prevalence from 2% to 27%, all containing the vanA gene and common resistance genes like ermB and tetM.
  • The findings highlight a concerning trend in VREfm's persistence and genetic variability due to horizontal gene transfer, emphasizing the complexity of its resistance mechanisms.
View Article and Find Full Text PDF
Article Synopsis
  • VREfm is a significant healthcare-acquired pathogen that can lead to serious bloodstream infections, and previous studies focused on its presence within healthcare facilities.
  • A study involving 710 clinical isolates collected from 2017-2022 revealed that nearly half of the isolates formed genetically similar clusters, indicating a high rate of transmission in the hospital.
  • Comparison with a large database of VREfm genomes over 20 years showed a notable shift in the populations of VREfm within hospitals, suggesting that antimicrobial peptides like bacteriocin T8 might play a crucial role in the emergence and persistence of these strains.
View Article and Find Full Text PDF
Article Synopsis
  • Enterococci are part of the gut microbiota but can cause serious infections, especially in immunocompromised patients, with increased antibiotic resistance, particularly to vancomycin.
  • Whole-genome sequencing revealed that a patient with recurrent severe bloodstream infections had been colonized by closely related strains for years, leading to the emergence of resistant isolates.
  • The combination of phage therapy and antibiotics led to significant clinical improvement and reduced VRE levels, although an antibody response against the phages contributed to treatment failure later on, illustrating both the potential and challenges of phage therapy for resistant infections.
View Article and Find Full Text PDF

: Vancomisin-resistant (VRE), is a resistant microorganism that colonizes and causes infections in hospitalized patients. The aim of this study was to show the spread of vancomycin-resistant (VREfm) step-by-step in all intensive care units, which started with the growth of VREfm on 2 December 2021 in the blood culture of a patient hospitalized in the anesthesia intensive care unit of our hospital and was found to have reached epidemic size in the surveys. : Rectal swab samples were taken from all patients hospitalized in intensive care units, VRE colonization was determined, the and resistance genes associated with the vancomycin resistance of VREfm isolates were determined by PCR method, and clonal association analysis was performed by Arbitrarily Primed-PCR (AP-PCR) and PFGE (pulsed-field gel electrophoresis).

View Article and Find Full Text PDF

Between 2010 and 2015 the incidence of vancomycin-resistant (VRE) in Norway increased dramatically. Hence, we selected (1) a random subset of vancomycin-resistant enterococci (VRE) from the Norwegian Surveillance System for Communicable Diseases (2010-15; =239) and (2) Norwegian vancomycin-susceptible (VSE) bacteraemia isolates from the national surveillance system for antimicrobial resistance in microbes (2008 and 2014; =261) for further analysis. Whole-genome sequences were collected for population structure, gene cluster, mobile genetic element and virulome analysis, as well as antimicrobial susceptibility testing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!